FCM
ACAD icon

Frontier Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-823,586
Closed -$25.8M 270
2023
Q4
$25.8M Buy
823,586
+65,973
+9% +$2.07M 0.26% 137
2023
Q3
$15.8M Buy
757,613
+107,903
+17% +$2.25M 0.17% 166
2023
Q2
$15.6M Buy
649,710
+115,655
+22% +$2.77M 0.15% 170
2023
Q1
$10.1M Buy
534,055
+173,178
+48% +$3.26M 0.1% 194
2022
Q4
$5.75M Sell
360,877
-123,686
-26% -$1.97M 0.06% 225
2022
Q3
$7.93M Sell
484,563
-81,760
-14% -$1.34M 0.09% 213
2022
Q2
$7.98M Sell
566,323
-312,667
-36% -$4.41M 0.09% 220
2022
Q1
$21.3M Sell
878,990
-177,723
-17% -$4.3M 0.19% 163
2021
Q4
$24.7M Buy
1,056,713
+667,144
+171% +$15.6M 0.2% 157
2021
Q3
$6.47M Sell
389,569
-657,778
-63% -$10.9M 0.05% 243
2021
Q2
$25.5M Buy
1,047,347
+585,970
+127% +$14.3M 0.19% 168
2021
Q1
$11.9M Sell
461,377
-497,315
-52% -$12.8M 0.09% 211
2020
Q4
$51.3M Sell
958,692
-35,347
-4% -$1.89M 0.38% 96
2020
Q3
$41M Sell
994,039
-192,445
-16% -$7.94M 0.36% 103
2020
Q2
$57.5M Sell
1,186,484
-168,971
-12% -$8.19M 0.51% 67
2020
Q1
$57.3M Buy
+1,355,455
New +$57.3M 0.64% 53
2018
Q2
Sell
-289,443
Closed -$6.5M 299
2018
Q1
$6.5M Buy
289,443
+201,709
+230% +$4.53M 0.05% 260
2017
Q4
$2.64M Sell
87,734
-318,787
-78% -$9.6M 0.02% 276
2017
Q3
$15.3M Sell
406,521
-265,188
-39% -$9.99M 0.11% 214
2017
Q2
$18.7M Buy
671,709
+36,021
+6% +$1M 0.14% 199
2017
Q1
$21.9M Buy
635,688
+260,815
+70% +$8.97M 0.16% 189
2016
Q4
$10.8M Sell
374,873
-258,817
-41% -$7.46M 0.08% 234
2016
Q3
$20.2M Buy
633,690
+362,459
+134% +$11.5M 0.16% 182
2016
Q2
$8.8M Sell
271,231
-10,968
-4% -$356K 0.07% 245
2016
Q1
$7.89M Sell
282,199
-63,185
-18% -$1.77M 0.06% 253
2015
Q4
$12.3M Buy
+345,384
New +$12.3M 0.1% 232